COO vs. BLCO, ALC, HOLX, ALNY, GMAB, WAT, AVTR, LH, PHG, and ILMN
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include Bausch + Lomb (BLCO), Alcon (ALC), Hologic (HOLX), Alnylam Pharmaceuticals (ALNY), Genmab A/S (GMAB), Waters (WAT), Avantor (AVTR), Laboratory Co. of America (LH), Koninklijke Philips (PHG), and Illumina (ILMN). These companies are all part of the "medical" sector.
Bausch + Lomb (NYSE:BLCO) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.
11.1% of Bausch + Lomb shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Cooper Companies had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 9 mentions for Cooper Companies and 8 mentions for Bausch + Lomb. Bausch + Lomb's average media sentiment score of 0.30 beat Cooper Companies' score of -0.28 indicating that Cooper Companies is being referred to more favorably in the news media.
Cooper Companies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Cooper Companies has a net margin of 7.93% compared to Cooper Companies' net margin of -6.27%. Bausch + Lomb's return on equity of 8.79% beat Cooper Companies' return on equity.
Bausch + Lomb presently has a consensus target price of $19.50, suggesting a potential upside of 31.85%. Cooper Companies has a consensus target price of $109.48, suggesting a potential upside of 23.23%. Given Cooper Companies' higher possible upside, analysts clearly believe Bausch + Lomb is more favorable than Cooper Companies.
Bausch + Lomb has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.
Cooper Companies received 586 more outperform votes than Bausch + Lomb when rated by MarketBeat users. Likewise, 66.67% of users gave Cooper Companies an outperform vote while only 37.93% of users gave Bausch + Lomb an outperform vote.
Summary
Cooper Companies beats Bausch + Lomb on 16 of the 18 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
